Exploratory Studies With BT-11
暂无分享,去创建一个
Raquel Hontecillas | Josep Bassaganya-Riera | Casandra Philipson | Adria Carbo | J. Bassaganya-Riera | R. Hontecillas | C. Philipson | A. Carbo | B. Jortner | J. Hinckley | M. Ehrich | S. Werre | Philippe Bissel | Katie Boes | Jonathan Hinckley | Bernard S Jortner | Geraldine Magnin-Bissel | Stephen R Werre | Marion Ehrich | Noah Philipson | Richard D Gandour | R. Gandour | G. Magnin-Bissel | P. Bissel | K. Boes | Noah Philipson | Adria Carbo
[1] R. Guy,et al. International Conference on Harmonisation , 2014 .
[2] W. Stenson. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response? , 1995, Gastroenterology.
[3] L. Brandt,et al. Pharmacotherapy of inflammatory bowel disease. Part 2. Metronidazole. , 1983, Postgraduate medicine.
[4] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[5] Raquel Hontecillas,et al. Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory Drugs That Target Lanthionine Synthetase C-Like Protein 2 , 2012, PloS one.
[6] V. Moser. Neurobehavioral Screening in Rodents , 1999, Current protocols in toxicology.
[7] M. Camilleri. GI clinical research 2002-2003: the year in review. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] J. Bassaganya-Riera,et al. Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes. , 2014, Current drug targets.
[9] S. Stegemann,et al. When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] A. Bleyer,et al. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. , 2006 .
[11] C. Stewart,et al. Chapter 5 – Acute, Subacute, Subchronic, and Chronic General Toxicity Testing for Preclinical Drug Development , 2017 .
[12] B. Sobral,et al. Abscisic Acid Regulates Inflammation via Ligand-binding Domain-independent Activation of Peroxisome Proliferator-activated Receptor γ* , 2010, The Journal of Biological Chemistry.